Dopamine transporter genotype influences the attention deficit in Korean boys with ADHD

Yonsei Medical Journal

Volumn 44, Issue 5, 2003, Pages 787-792

  Oh, Kang Seob ^a   Shin, Dong Won ^a   Oh, Guk Taek ^a   Noh, Kyung Sun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

ADHD; Attention deficits; DAT1 genotype

Indexed keywords

DOPAMINE TRANSPORTER; GENOMIC DNA;

3' UNTRANSLATED REGION; ARTICLE; ATTENTION DEFICIT DISORDER; BASE PAIRING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA DETERMINATION; DNA EXTRACTION; GENE AMPLIFICATION; GENOTYPE; HUMAN; KOREA; MALE; MENTAL HOSPITAL; OUTPATIENT DEPARTMENT; PSYCHIATRIST; PSYCHOLOGIC TEST; RANK SUM TEST; RESPONSE TIME; SCHOOL CHILD; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0242659238     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2003.44.5.787     Document Type: Article

References (41)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Press; 1994.
2. Barkley RA. Attention deficit hyperactivity disorder. A handbook for diagnosis and treatment. New York: Guilford Press; 1990.
3. Faraone SV, Doyle AE. The nature and heritability of attention-deficit/hyperactivity Disorder. Child Adolesc Psychiatr Clin North Am 2001;10:299-316, viii-ix.
4. Swanson J, Posner M, Fusella J, Wasdell M, Sommer T, Fan J. Genes and attention deficit hyperactivity disorder. Curr Psychiatry Rep 2001;3:92-100.
5. Sherman DK, Iacono WG, McGue M. Attention-deficit hyperactivity disorder dimensions: a twin study of inattention and impulsivity-hyperactivity. J Am Acad Child Adolesc Psychiatry 1997;36:745-53.
6. Greenhill LL. Pharmacologic treatment of attention deficit hyperactivity disorder. Psychiatr Clin North Am 1992;15:1-27.
7. Elia J, Borcherding BG, Rapoport JL, Keysor CS. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res 1991;36:141-55.
8. Casat C, Pleasant D, Fleet J. A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacol Bull 1987;23:120-2.
9. Rapport M, Denney C, DuPaul G, Gardner M. Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness and response prediction in 76 children. J Am Acad Child Adolesc Psychiatry 1994;33:882-93.
10. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 1996;379:606-12.
11. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci 1998;95:4029-34.
12. Gainetdinov RR, Jones SR, Caron MG. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry 1999;46:303-11.
13. Spielewoy C, Roubert C, Hamon M, Nosten-Bertrand M, Betancur C, Giros B. Behavioural disturbances associated with hyperdopaminergia in dopamine-transoprter knockout mice. Behav Pharmacol 2000;11:279-90.
14. Vandenbergh DJ, Persico AM, Uhl GR. A human dopamine transporter cDNA predicts reduced glycosylation, displasys a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Mol Brain Res 1992; 15:161-6.
15. Mitchelle RJ, Howlett S, Earl L, White NG, McComb J, Schanfield MS, et al. Distribution of the 3′ VNTR polymorphisom in the human dopamine transporter gene in world populations. Hum Biol 2000;72:295-304.
16. Nakatome M, Honda K, Islam MN, Terada M, Yamazaki M, Kuroki H, et al. Amplification of DAT1 (human dopamine transporter gene)3′ variable region in the Japanese population. Hum Hered 1995;45:262-5.
17. Nakatome M, Honda K, Tun Z, Kato Y, Harihara S, Omoto K, et al. Genetic polymorphism of the 3′ VNTR region of the human dopaminergic function gene DAT1 (human dopamine trasporter gene) in the Mongolian population. Hum Biol 1996;68:509-15.
18. Shin DW, Noh KS, Oh KS, Lee MS. Association between attention deficit hyperactivity disorder and dopamine transporter gene (DAT1) polymorphism in Korean. J Korean Neuropsychiatr Assoc 2002;41:612-8.
19. Cook EH, Stein MA, KrasowskiMD, Cox NJ, Deborah MO, Kieffer JE, et al. Association of attention-deficit disorder and dopamine transporter gene. Am J Hum Genet 1995;56:993-8.
20. LA Hoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996;1:121-4.
21. Gill M, Daly G, Heron S, Hawi Z, Fitgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997;2:311-3.
22. Waldman ID, Rowe DC, Abramowitz A, Kozel ST, Mohr JH, Sherman SL, et al. Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 1998;63:1767-76.
23. Curran S, Mill J, Tahir E, Kent L, Richards S, Gould A, et al. Association study of a dopamine transporter polymorphism and attention deficit UK and Turkish samples. Mol Psychiatry 2001;6:425-8.
24. Holmes J, Payton A, Barrett JH, Hever T, Fitzpatrick H, Trumper AL, et al. A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry 2000;5:523-30.
25. Roman T, Schmitz M, Polanczk G, Eizirik M, Rohde LA, Hutz MH. Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. Am J Med Genet 2001;105:471-8.
26. Young SE, Smolen A, Corley RP, Krauter KS, DeFries JC, Crowley TJ, et al. Dopamine transporter polymorphism associated with externalizing behavior problems in children. Am J Med Genet 2002;114:144-9.
27. Fan J, Wu Y, Fosa JA, Posner MI. Assessing the heritability of attentional networks. BMC Neurosci 2001;2:14.
28. Cornblatt BA, Risch NJ, Faris G, Friedman D, Erlenmeyer-Kimling L. The Continuous Performance Test, identical pairs version (CPT-IP): I. New findings about sustained attention in normal families. Psychiatr Res 1988;26:223-38.
29. Fossella J, Sommer T, Fan J, Wu Y, Swanson JM, Pfaff DW, et al. Assessing the molecular genetics of attention networks. BMC Neurosci 2002;3:14.
30. Greenberg LM. T.O.V.A. TM interpretation manual. Minneapolis, MN; 1991.
31. Levy F, Hay DA, McStephen M, Wood C, Waldman I. Attention-deficit hyperactivity disorder: a category or a continuum? genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiatry 1997;36:737-44.
32. Stevenson J. Evidence for a genetic etiology in hyperactivity in children. Behav Genet 1992;22:337-44.
33. Miller GM, Madras BK. Polymorphisms in the 3′-untranslated region of human and monkey dopamine transporter genes affect reporter gene expression. Mol Psychiatry 2002;7:44-55.
34. Mill J, Asherson P, Browes C, D'Souza U, Craig I. Expression of the dopamine transporter gene is regulated. by the 3′ UTR VNTR: Evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet 2002;114:975-9.
35. Fuke S, Suo S, Takahashi N, Koike H, Sasagawa N, Ishiura S. The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J 2001;1:152-6.
36. Heinz A, Goldman C, Jones DW, Palmour R, Hommer D, Gorey JG, et al. Genotype influences in vivo dopamine transporter availability in human striatum. Neuropsychopharmacology 2000;22:133-9.
37. Jacobsen L, Staley J, Zoghbi SS, Seibyl JP, Kosten TR, Innis RB, et al. Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry 2000;157:1700-3.
38. Chen WJ, Faraone SV. Sustained attenion deficits as markers of genetic susceptibility to Schizophrenia. Am J Med Genet 2000;97:52-57.
39. Cornblatt BA, Malhotra AK. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. Am J Med Genet 2001;105:11-5.
40. Rowe DC, Stever C, Chase D, Sherman S, Abramowitz A, Waldman ID. Two dopamine genes related to reports of childhood retrospective inattention and conduct disorder symptoms. Mol Psychiatry 2001;6:429-33.
41. Posner MI, Petersen SE. The attention system of the human brain. Annu Rev Neurosci 1990;13:25-42.